Report Code : CVMI24071631 | Published Date : July 16, 2024
nan




Reasons To Buy

nan




Scope

nan

Key Players

  • Bayer AG
  • Merck & Co.
  • Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Abbott Laboratories
Global Polycystic Ovary Syndrome (PCOS) Drugs Market Report

Global Polycystic Ovary Syndrome (PCOS) Drugs Market Report

    1. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report - Preface
    1. 2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Drug Class
      2. 2.1.2 By Mechanism of Action
      3. 2.1.3 By Route of Administration
      4. 2.1.4 By End User
      5. 2.1.5 By Region
    3. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Drug Class, By Mechanism of Action, By Route of Administration, By End User, By Country
    3. 3.3. Opportunities – By Drug Class, By Mechanism of Action, By Route of Administration, By End User, By Country
    4. 3.4. Trends – By Drug Class, By Mechanism of Action, By Route of Administration, By End User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report – DROTs Impact Analysis
    4. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Polycystic Ovary Syndrome (PCOS) Drugs Market, By Drug Class, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Oral Contraceptives
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Insulin Sensitizing Agents
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Anti-Androgens
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Selective Estrogen Receptor Modulators (SERMs)
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 5.5 Gonadotropins
      1. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.6 Eflornithine (Topical Cream)
      1. 5.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. 5.7 Anti-Obesity Drugs
      1. 5.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Polycystic Ovary Syndrome (PCOS) Drugs Market, By Mechanism of Action, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hormonal Imbalance Correction
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Insulin Resistance Management
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Anti-Androgen Effects
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Ovulation Induction
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 6.5 Symptom Management
      1. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Polycystic Ovary Syndrome (PCOS) Drugs Market, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Oral
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Injectable
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Topical
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Polycystic Ovary Syndrome (PCOS) Drugs Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Hospitals
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Clinics
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Ambulatory Surgical Centers
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Homecare Settings.
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    9. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 North America
      1. 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 9.2 Europe
      1. 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 9.3 Asia-Pacific
      1. 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 9.4 Latin America
      1. 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 9.5 Middle East & Africa
      1. 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      6. 9.6 Global Polycystic Ovary Syndrome (PCOS) Drugs Market - Opportunity Analysis Index, By Drug Class, By Mechanism of Action, By Route of Administration, By End User, and Region, 2024 - 2031
    10. North America Global Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      10.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Oral Contraceptives
      2. 10.1.2 Insulin Sensitizing Agents
      3. 10.1.3 Anti-Androgens
      4. 10.1.4 Selective Estrogen Receptor Modulators (SERMs)
      5. 10.1.5 Gonadotropins
      6. 10.1.6 Eflornithine (Topical Cream)
      7. 10.1.7 Anti-Obesity Drugs
      10.2 By Mechanism of Action Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Hormonal Imbalance Correction
      2. 10.2.2 Insulin Resistance Management
      3. 10.2.3 Anti-Androgen Effects
      4. 10.2.4 Ovulation Induction
      5. 10.2.5 Symptom Management
      10.3 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Oral
      2. 10.3.2 Injectable
      3. 10.3.3 Topical
      10.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Hospitals
      2. 10.4.2 Clinics
      3. 10.4.3 Ambulatory Surgical Centers
      4. 10.4.4 Homecare Settings.
      10.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.5.1 United States
      2. 10.5.2 Canada
      10.6 North America Global Polycystic Ovary Syndrome (PCOS) Drugs Market – Opportunity Analysis Index, By Drug Class, By Mechanism of Action, By Route of Administration, By End User, and Country, 2024 - 2031
      10.7 Regional Trends Analysis
      10.8 North America Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report - Company Profiles
      1. 10.8.1 Company 1 (United States)
      2. 10.8.2 Company 2 (Canada)
      3. 10.8.3 Company 3 (Canada)
    11. Europe Global Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      11.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Oral Contraceptives
      2. 11.1.2 Insulin Sensitizing Agents
      3. 11.1.3 Anti-Androgens
      4. 11.1.4 Selective Estrogen Receptor Modulators (SERMs)
      5. 11.1.5 Gonadotropins
      6. 11.1.6 Eflornithine (Topical Cream)
      7. 11.1.7 Anti-Obesity Drugs
      11.2 By Mechanism of Action Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Hormonal Imbalance Correction
      2. 11.2.2 Insulin Resistance Management
      3. 11.2.3 Anti-Androgen Effects
      4. 11.2.4 Ovulation Induction
      5. 11.2.5 Symptom Management
      11.3 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Oral
      2. 11.3.2 Injectable
      3. 11.3.3 Topical
      11.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Hospitals
      2. 11.4.2 Clinics
      3. 11.4.3 Ambulatory Surgical Centers
      4. 11.4.4 Homecare Settings.
      11.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.5.1 Germany
      2. 11.5.2 United Kingdom
      3. 11.5.3 France
      4. 11.5.4 Spain
      5. 11.5.5 Italy
      6. 11.5.6 Russia
      7. 11.5.7 Netherlands
      8. 11.5.8 Poland
      9. 11.5.9 Rest of Europe
      11.6 Europe Global Polycystic Ovary Syndrome (PCOS) Drugs Market – Opportunity Analysis Index, By Drug Class, By Mechanism of Action, By Route of Administration, By End User, and Country, 2024 - 2031
      11.7 Regional Trends Analysis
      11.8 Europe Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report - Company Profiles
      1. 11.8.1 Company 1 (Germany)
      2. 11.8.2 Company 2 (United Kingdom)
      3. 11.8.3 Company 3 (United Kingdom)
    12. Asia-Pacific Global Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      12.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Oral Contraceptives
      2. 12.1.2 Insulin Sensitizing Agents
      3. 12.1.3 Anti-Androgens
      4. 12.1.4 Selective Estrogen Receptor Modulators (SERMs)
      5. 12.1.5 Gonadotropins
      6. 12.1.6 Eflornithine (Topical Cream)
      7. 12.1.7 Anti-Obesity Drugs
      12.2 By Mechanism of Action Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Hormonal Imbalance Correction
      2. 12.2.2 Insulin Resistance Management
      3. 12.2.3 Anti-Androgen Effects
      4. 12.2.4 Ovulation Induction
      5. 12.2.5 Symptom Management
      12.3 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Oral
      2. 12.3.2 Injectable
      3. 12.3.3 Topical
      12.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Hospitals
      2. 12.4.2 Clinics
      3. 12.4.3 Ambulatory Surgical Centers
      4. 12.4.4 Homecare Settings.
      12.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.5.1 China
      2. 12.5.2 Japan
      3. 12.5.3 India
      4. 12.5.4 South Korea
      5. 12.5.5 Australia & NZ
      6. 12.5.6 ASEAN
      7. 12.5.7 Rest of Asia-Pacific
      12.6 Asia-Pacific Global Polycystic Ovary Syndrome (PCOS) Drugs Market – Opportunity Analysis Index, By Drug Class, By Mechanism of Action, By Route of Administration, By End User, and Country, 2024 - 2031
      12.7 Regional Trends Analysis
      12.8 Asia-Pacific Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report - Company Profiles
      1. 12.8.1 Company 1 (China)
      2. 12.8.2 Company 2 (Japan)
      3. 12.8.3 Company 3 (Japan)
    13. Latin America Global Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      13.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Oral Contraceptives
      2. 13.1.2 Insulin Sensitizing Agents
      3. 13.1.3 Anti-Androgens
      4. 13.1.4 Selective Estrogen Receptor Modulators (SERMs)
      5. 13.1.5 Gonadotropins
      6. 13.1.6 Eflornithine (Topical Cream)
      7. 13.1.7 Anti-Obesity Drugs
      13.2 By Mechanism of Action Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Hormonal Imbalance Correction
      2. 13.2.2 Insulin Resistance Management
      3. 13.2.3 Anti-Androgen Effects
      4. 13.2.4 Ovulation Induction
      5. 13.2.5 Symptom Management
      13.3 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Oral
      2. 13.3.2 Injectable
      3. 13.3.3 Topical
      13.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Hospitals
      2. 13.4.2 Clinics
      3. 13.4.3 Ambulatory Surgical Centers
      4. 13.4.4 Homecare Settings.
      13.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.5.1 Brazil
      2. 13.5.2 Mexico
      3. 13.5.3 Argentina
      4. 13.5.4 Peru
      5. 13.5.5 Colombia
      6. 13.5.6 Rest of Latin America
      13.6 Latin America Global Polycystic Ovary Syndrome (PCOS) Drugs Market – Opportunity Analysis Index, By Drug Class, By Mechanism of Action, By Route of Administration, By End User, and Country, 2024 - 2031
      13.7 Regional Trends Analysis
      13.8 Latin America Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report - Company Profiles
      1. 13.8.1 Company 1 (Brazil)
      2. 13.8.2 Company 2 (Mexico)
      3. 13.8.3 Company 3 (Mexico)
    14. Middle East & Africa Global Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      14.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.1.1 Oral Contraceptives
      2. 14.1.2 Insulin Sensitizing Agents
      3. 14.1.3 Anti-Androgens
      4. 14.1.4 Selective Estrogen Receptor Modulators (SERMs)
      5. 14.1.5 Gonadotropins
      6. 14.1.6 Eflornithine (Topical Cream)
      7. 14.1.7 Anti-Obesity Drugs
      14.2 By Mechanism of Action Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.2.1 Hormonal Imbalance Correction
      2. 14.2.2 Insulin Resistance Management
      3. 14.2.3 Anti-Androgen Effects
      4. 14.2.4 Ovulation Induction
      5. 14.2.5 Symptom Management
      14.3 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.3.1 Oral
      2. 14.3.2 Injectable
      3. 14.3.3 Topical
      14.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.4.1 Hospitals
      2. 14.4.2 Clinics
      3. 14.4.3 Ambulatory Surgical Centers
      4. 14.4.4 Homecare Settings.
      14.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.5.1 Saudi Arabia
      2. 14.5.2 UAE
      3. 14.5.3 South Africa
      4. 14.5.4 Egypt
      5. 14.5.5 Israel
      6. 14.5.6 Rest of Middle East and Africa
      14.6 Middle East & Africa Global Polycystic Ovary Syndrome (PCOS) Drugs Market – Opportunity Analysis Index, By Drug Class, By Mechanism of Action, By Route of Administration, By End User, and Country, 2024 - 2031
      14.7 Regional Trends Analysis
      14.8 Middle East & Africa Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report - Company Profiles
      1. 14.8.1 Company 1 (Saudi Arabia)
      2. 14.8.2 Company 2 (UAE)
      3. 14.8.3 Company 3 (UAE)
    15. Competition Landscape
      15.1 Strategic Dashboard of Top Market Players
      15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 15.2.1 Bayer AG
      2. 15.2.2 Merck & Co.
      3. 15.2.3 Inc.
      4. 15.2.4 Teva Pharmaceutical Industries Ltd.
      5. 15.2.5 Novartis AG
      6. 15.2.6 Abbott Laboratories
    16. Data Collection Method and Research Approach
    17. Principal Presumptions and Acronyms